Aurobindo Pharma has reported results for third quarter ended December 31, 2012.
The company has posted 11-fold rise in its net profit of Rs 144.28 crore for the quarter as compared to Rs 12.93 crore for the same quarter in the previous year. Total income from operation of the company has increased by 19.01% at Rs 1432.45 crore for quarter under review as compared to Rs 1203.61 crore for the quarter ended December 31, 2011.
On consolidated basis, the company has reported a net profit of Rs 91.81 crore for the quarter as compared to a net loss of Rs 28.54 crore for the same quarter in the previous year. Total income of the company has increased by 22.17% at Rs 1575.73 crore for quarter under review as compared to Rs 1289.74 crore for the quarter ended December 31, 2011.
